Profile - To The Moon

AntMan

Posts · 7Posts · 7
Following · 0Following · 0
Followers · 0Followers · 0

- AntManAntMan
  ·2021-06-03
  Superb
  391 Comment
  Like
  Share
  Report
- AntManAntMan
  ·2021-03-19
  Red Red Red
  Nasdaq tumbles 3% as soaring yields hit tech shares, S&P 500 closes 1.5% lower
  Technology shares led the U.S. stock market lower on Thursday as a spike in bond yields fueled conce
  Nasdaq tumbles 3% as soaring yields hit tech shares, S&P 500 closes 1.5% lower
  566 Comment
  Like
  Share
  Report
- AntManAntMan
  ·2021-03-19
  Red Red Red ......
  Sorry, this post has been deleted
  376 Comment
  Like
  Share
  Report
- AntManAntMan
  ·2021-03-19
  Omg
  The Fed plans to keep interest rates low -- so why do interest rates keep rising?
  Mortgage rates are now at the highest point since June and could go even higher even if the Federal
  The Fed plans to keep interest rates low -- so why do interest rates keep rising?
  454 Comment
  5
  Share
  Report
- AntManAntMan
  ·2021-03-17
  WoW.... looking forward to that day.
  Sorry, this post has been deleted
  291 Comment
  2
  Share
  Report
- AntManAntMan
  ·2021-03-01
  Ok
  EU audits Indian vaccine maker as AstraZeneca looks to boost supplies to the bloc - source
  MILAN (Reuters) - Europe’s drug regulator is auditing the manufacturing site of the Serum Institute
  EU audits Indian vaccine maker as AstraZeneca looks to boost supplies to the bloc - source
  157 Comment
  2
  Share
  Report
No following yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3573635568928452","uuid":"3573635568928452","gmtCreate":1610595399121,"gmtModify":1614584148081,"name":"AntMan","pinyin":"antman","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/d1008fe6c589933cfd307a9e79a22cd8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":9,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":111766949,"gmtCreate":1622700634581,"gmtModify":1704189216086,"author":{"id":"3573635568928452","authorId":"3573635568928452","name":"AntMan","avatar":"https://static.tigerbbs.com/d1008fe6c589933cfd307a9e79a22cd8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573635568928452","authorIdStr":"3573635568928452"},"themes":[],"htmlText":"Superb","listText":"Superb","text":"Superb","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/111766949","isVote":1,"tweetType":1,"viewCount":391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327418913,"gmtCreate":1616116367732,"gmtModify":1704791134043,"author":{"id":"3573635568928452","authorId":"3573635568928452","name":"AntMan","avatar":"https://static.tigerbbs.com/d1008fe6c589933cfd307a9e79a22cd8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573635568928452","authorIdStr":"3573635568928452"},"themes":[],"htmlText":"Red Red Red","listText":"Red Red Red","text":"Red Red Red","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327418913","repostId":"1103812798","repostType":4,"repost":{"id":"1103812798","kind":"news","pubTimestamp":1616111217,"share":"https://ttm.financial/m/news/1103812798?lang=&edition=fundamental","pubTime":"2021-03-19 07:46","market":"us","language":"en","title":"Nasdaq tumbles 3% as soaring yields hit tech shares, S&P 500 closes 1.5% lower","url":"https://stock-news.laohu8.com/highlight/detail?id=1103812798","media":"cnbc","summary":"Technology shares led the U.S. stock market lower on Thursday as a spike in bond yields fueled conce","content":"<div>\n<p>Technology shares led the U.S. stock market lower on Thursday as a spike in bond yields fueled concern about equity valuations and prompted investors to sell growth-focused high flyers.\nThe Nasdaq ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/17/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq tumbles 3% as soaring yields hit tech shares, S&P 500 closes 1.5% lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq tumbles 3% as soaring yields hit tech shares, S&P 500 closes 1.5% lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-19 07:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/17/stock-market-open-to-close-news.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Technology shares led the U.S. stock market lower on Thursday as a spike in bond yields fueled concern about equity valuations and prompted investors to sell growth-focused high flyers.\nThe Nasdaq ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/17/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.cnbc.com/2021/03/17/stock-market-open-to-close-news.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1103812798","content_text":"Technology shares led the U.S. stock market lower on Thursday as a spike in bond yields fueled concern about equity valuations and prompted investors to sell growth-focused high flyers.\nThe Nasdaq Composite dropped 3% to 13,116.17 for its worst day since Feb. 25 as Apple, Amazon and Netflix all fell more than 3%. Tesla slipped nearly 7%. The S&P 500 slid 1.5% to 3,915.46, falling from a record closing high reached in the previous session. The Dow Jones Industrial Average fell 153.07 points, or 0.5%, to 32,862.30 after hitting a new intraday record earlier in the day amid a rally in bank stocks.\nThe 10-year Treasury yield jumped 11 basis points above 1.75% at its session high, reaching its highest level since January 2020. The 30-year rate also climbed 6 basis points at one point, breaching the 2.5% level for the first time since August 2019. The jump in bond yields came after the Federal Reserve expressed its willingness to allow an overshoot in inflation. Rising rates can have an outsized impact on growth stocks as they make their future returns less valuable today.\n“Risk of rates rising too fast remains a key concern,” said Craig Johnson, technical market strategist at Piper Sandler. “Buying pressure has not been equal over the last several weeks as growth stocks lag behind due to headwinds from higher interest rates.”\nBank stocks outperformed as higher interest rates tend to improve their profit margins. Banks can earn more from the widening gap between the rate they borrow at in the short term and the rate they lend out at in the long term. U.S. Bancorp and Wells Fargo popped 3.3% and 2.4%, respectively. JPMorgan jumped 1.7%, while Bank of America gained 2.6%.\nInvestors also digested a mixed bag of economic data Thursday.Weekly initial jobless claims totaled 770,000 for the week ended March 13, worse than an estimate of 700,000, according to economists polled by Dow Jones.\nMeanwhile, the Philadelphia Federal Reserve’s manufacturing index showed a reading of 51.8, well exceeding Dow Jones consensus of 22.0 and hitting the highest level for the gauge since 1973.\nThe energy sector was the biggest loser with a 4.7% decline Thursday amid a drop in oil prices. WTI crude futures slid more than 7% to $60 per barrel, falling for a fifth straight day and suffering its worst day since September.\nThe blue-chip Dow closed above 33,000 for the first time on Wednesday after the Fed said it does not expect to hike interest rates through 2023.\nFed Chair Jerome Powell reiterated that the central bank wants to see inflation consistently above its 2% target and material improvement in the U.S. labor market before considering changes to rates or its monthly bond purchases.\n“By saying that they’re willing to let inflation run hot at a time inflation concerns are rising is another way for the Fed to say that they are willing to let long-term interest rates rise further,” said Matt Maley, chief market strategist at Miller Tabak.\nThe Fed upgraded its economic outlook, expecting to see gross domestic product grow 6.5% in 2021 and inflation rise 2.2% this year as measured by personal consumption expenditures. The central bank’s stated goal is to keep inflation at 2% over the long run.","news_type":1},"isVote":1,"tweetType":1,"viewCount":566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327411482,"gmtCreate":1616116347846,"gmtModify":1704791132752,"author":{"id":"3573635568928452","authorId":"3573635568928452","name":"AntMan","avatar":"https://static.tigerbbs.com/d1008fe6c589933cfd307a9e79a22cd8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573635568928452","authorIdStr":"3573635568928452"},"themes":[],"htmlText":"Red Red Red ......","listText":"Red Red Red ......","text":"Red Red Red ......","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327411482","repostId":"1103812798","repostType":4,"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327585414,"gmtCreate":1616110582638,"gmtModify":1704791017336,"author":{"id":"3573635568928452","authorId":"3573635568928452","name":"AntMan","avatar":"https://static.tigerbbs.com/d1008fe6c589933cfd307a9e79a22cd8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573635568928452","authorIdStr":"3573635568928452"},"themes":[],"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327585414","repostId":"2120163660","repostType":4,"repost":{"id":"2120163660","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1616078340,"share":"https://ttm.financial/m/news/2120163660?lang=&edition=fundamental","pubTime":"2021-03-18 22:39","market":"hk","language":"en","title":"The Fed plans to keep interest rates low -- so why do interest rates keep rising?","url":"https://stock-news.laohu8.com/highlight/detail?id=2120163660","media":"Dow Jones","summary":"Mortgage rates are now at the highest point since June and could go even higher even if the Federal ","content":"<p>Mortgage rates are now at the highest point since June and could go even higher even if the Federal Reserve doesn't change its policy</p><p>The Federal Reserve is planning to stay the course in keeping interest rates low -- but that isn't necessarily music to home buyers' ears.</p><p>On Wednesday, the Federal Reserve signaled that it won't raise interest rates  until 2023 at the earliest, even though some observers have voiced concerns about rising inflation. As of now, seven of the 18 Fed officials expect a rate hike to come in 2023, while four think <a href=\"https://laohu8.com/S/AONE\">one</a> could happen next year.</p><p>Investors happily greeted the news , with the Dow Jones Industrial Average  and the S&amp;P 500   both notching intraday records Wednesday following the Fed's announcement. Whether the Fed's policy is similarly auspicious for home buyers or people looking to refinance their existing mortgages remains to be seen.</p><p>Since the start of the year, the benchmark rate on the 30-year fixed-rate mortgage has risen more than 40 basis points, according to data from Freddie Mac.</p><p>As of Thursday  reported. It's the highest level that the benchmark mortgage rate has hit since June of last year.</p><p>Meanwhile, the average rates on the 15-year fixed-rate mortgage and the 5-year Treasury-indexed adjustable-rate mortgage both increased by two basis points, to 2.4% and 2.79% respectively.</p><p>\"The Fed funds rate itself has no impact on mortgage rates,\" said Tendayi Kapfidze, chief economist at <a href=\"https://laohu8.com/S/TREE\">LendingTree</a> <a href=\"https://laohu8.com/S/TREE.UK\">$(TREE.UK)$</a>, in explaining the Fed's policy decision didn't stem the rise in mortgage rates this week. The Federal Reserve controls short-term interest rates. But mortgage rates are long term rates, and mortgage lenders take their cues from the bond market when setting the rates they charge to borrowers.</p><p>In particular, mortgage rates roughly track the direction of the 10-year Treasury . But even that relationship isn't foolproof. \"This relationship can vary,\" Kapfidze said. \"10-yr Treasury rates were on an upward trend from August 2020, but mortgage rates were still falling until February.\"</p><p>Mortgage rates have risen quickly in recent weeks, reaching the highest level since July, as investors grew increasingly concerned about inflation. With Americans now receiving the stimulus checks approved as part of the $1.9 trillion American Rescue Plan, some analysts expect people to rush out and spend that money, causing prices to go up for consumer goods and services.</p><p>Still, the Fed's stance and policy decisions could have some influence on mortgage rates, even if the central bank doesn't control them directly. Since the start of the pandemic, the Federal Reserve has ramped up its purchases of mortgage-backed securities in an effort to pump much needed liquidity into the market. Those purchases helped to push rates lower.</p><p>\"Reaffirming its commitment to ongoing asset purchases while acknowledging that a tapering is on the horizon at some point -- likely pretty far off -- should help slow the rise of mortgage rates,\" said Danielle Hale, chief economist at Realtor.com. Hale noted that she expects the overall upward trend in mortgage rates to continue.</p><p>But if the Fed reverses its policy regarding mortgage-backed securities, rates could quickly rise as lenders face liquidity constraints. Alternatively, if the Fed were to opt to ramp up its purchases of 10-year Treasury notes to stem long-term rates, then mortgage rates could drop, Kapfidze said.</p><p>Either way, mortgage rates remain very low by historical standards even if they're now above the 3% mark, and industry experts anticipate that demand for mortgages will remain strong.</p><p>The Mortgage Bankers Association \"continues to see a very strong housing market, with mortgage applications to buy a home increasing, even as refinance demand wanes,\" said Mike Fratantoni, the trade organization's chief economist. \"While mortgage rates are likely to move somewhat higher, the purchase market remains on track for a record year.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Fed plans to keep interest rates low -- so why do interest rates keep rising?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Fed plans to keep interest rates low -- so why do interest rates keep rising?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-18 22:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mortgage rates are now at the highest point since June and could go even higher even if the Federal Reserve doesn't change its policy</p><p>The Federal Reserve is planning to stay the course in keeping interest rates low -- but that isn't necessarily music to home buyers' ears.</p><p>On Wednesday, the Federal Reserve signaled that it won't raise interest rates  until 2023 at the earliest, even though some observers have voiced concerns about rising inflation. As of now, seven of the 18 Fed officials expect a rate hike to come in 2023, while four think <a href=\"https://laohu8.com/S/AONE\">one</a> could happen next year.</p><p>Investors happily greeted the news , with the Dow Jones Industrial Average  and the S&amp;P 500   both notching intraday records Wednesday following the Fed's announcement. Whether the Fed's policy is similarly auspicious for home buyers or people looking to refinance their existing mortgages remains to be seen.</p><p>Since the start of the year, the benchmark rate on the 30-year fixed-rate mortgage has risen more than 40 basis points, according to data from Freddie Mac.</p><p>As of Thursday  reported. It's the highest level that the benchmark mortgage rate has hit since June of last year.</p><p>Meanwhile, the average rates on the 15-year fixed-rate mortgage and the 5-year Treasury-indexed adjustable-rate mortgage both increased by two basis points, to 2.4% and 2.79% respectively.</p><p>\"The Fed funds rate itself has no impact on mortgage rates,\" said Tendayi Kapfidze, chief economist at <a href=\"https://laohu8.com/S/TREE\">LendingTree</a> <a href=\"https://laohu8.com/S/TREE.UK\">$(TREE.UK)$</a>, in explaining the Fed's policy decision didn't stem the rise in mortgage rates this week. The Federal Reserve controls short-term interest rates. But mortgage rates are long term rates, and mortgage lenders take their cues from the bond market when setting the rates they charge to borrowers.</p><p>In particular, mortgage rates roughly track the direction of the 10-year Treasury . But even that relationship isn't foolproof. \"This relationship can vary,\" Kapfidze said. \"10-yr Treasury rates were on an upward trend from August 2020, but mortgage rates were still falling until February.\"</p><p>Mortgage rates have risen quickly in recent weeks, reaching the highest level since July, as investors grew increasingly concerned about inflation. With Americans now receiving the stimulus checks approved as part of the $1.9 trillion American Rescue Plan, some analysts expect people to rush out and spend that money, causing prices to go up for consumer goods and services.</p><p>Still, the Fed's stance and policy decisions could have some influence on mortgage rates, even if the central bank doesn't control them directly. Since the start of the pandemic, the Federal Reserve has ramped up its purchases of mortgage-backed securities in an effort to pump much needed liquidity into the market. Those purchases helped to push rates lower.</p><p>\"Reaffirming its commitment to ongoing asset purchases while acknowledging that a tapering is on the horizon at some point -- likely pretty far off -- should help slow the rise of mortgage rates,\" said Danielle Hale, chief economist at Realtor.com. Hale noted that she expects the overall upward trend in mortgage rates to continue.</p><p>But if the Fed reverses its policy regarding mortgage-backed securities, rates could quickly rise as lenders face liquidity constraints. Alternatively, if the Fed were to opt to ramp up its purchases of 10-year Treasury notes to stem long-term rates, then mortgage rates could drop, Kapfidze said.</p><p>Either way, mortgage rates remain very low by historical standards even if they're now above the 3% mark, and industry experts anticipate that demand for mortgages will remain strong.</p><p>The Mortgage Bankers Association \"continues to see a very strong housing market, with mortgage applications to buy a home increasing, even as refinance demand wanes,\" said Mike Fratantoni, the trade organization's chief economist. \"While mortgage rates are likely to move somewhat higher, the purchase market remains on track for a record year.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2120163660","content_text":"Mortgage rates are now at the highest point since June and could go even higher even if the Federal Reserve doesn't change its policyThe Federal Reserve is planning to stay the course in keeping interest rates low -- but that isn't necessarily music to home buyers' ears.On Wednesday, the Federal Reserve signaled that it won't raise interest rates  until 2023 at the earliest, even though some observers have voiced concerns about rising inflation. As of now, seven of the 18 Fed officials expect a rate hike to come in 2023, while four think one could happen next year.Investors happily greeted the news , with the Dow Jones Industrial Average  and the S&P 500   both notching intraday records Wednesday following the Fed's announcement. Whether the Fed's policy is similarly auspicious for home buyers or people looking to refinance their existing mortgages remains to be seen.Since the start of the year, the benchmark rate on the 30-year fixed-rate mortgage has risen more than 40 basis points, according to data from Freddie Mac.As of Thursday  reported. It's the highest level that the benchmark mortgage rate has hit since June of last year.Meanwhile, the average rates on the 15-year fixed-rate mortgage and the 5-year Treasury-indexed adjustable-rate mortgage both increased by two basis points, to 2.4% and 2.79% respectively.\"The Fed funds rate itself has no impact on mortgage rates,\" said Tendayi Kapfidze, chief economist at LendingTree $(TREE.UK)$, in explaining the Fed's policy decision didn't stem the rise in mortgage rates this week. The Federal Reserve controls short-term interest rates. But mortgage rates are long term rates, and mortgage lenders take their cues from the bond market when setting the rates they charge to borrowers.In particular, mortgage rates roughly track the direction of the 10-year Treasury . But even that relationship isn't foolproof. \"This relationship can vary,\" Kapfidze said. \"10-yr Treasury rates were on an upward trend from August 2020, but mortgage rates were still falling until February.\"Mortgage rates have risen quickly in recent weeks, reaching the highest level since July, as investors grew increasingly concerned about inflation. With Americans now receiving the stimulus checks approved as part of the $1.9 trillion American Rescue Plan, some analysts expect people to rush out and spend that money, causing prices to go up for consumer goods and services.Still, the Fed's stance and policy decisions could have some influence on mortgage rates, even if the central bank doesn't control them directly. Since the start of the pandemic, the Federal Reserve has ramped up its purchases of mortgage-backed securities in an effort to pump much needed liquidity into the market. Those purchases helped to push rates lower.\"Reaffirming its commitment to ongoing asset purchases while acknowledging that a tapering is on the horizon at some point -- likely pretty far off -- should help slow the rise of mortgage rates,\" said Danielle Hale, chief economist at Realtor.com. Hale noted that she expects the overall upward trend in mortgage rates to continue.But if the Fed reverses its policy regarding mortgage-backed securities, rates could quickly rise as lenders face liquidity constraints. Alternatively, if the Fed were to opt to ramp up its purchases of 10-year Treasury notes to stem long-term rates, then mortgage rates could drop, Kapfidze said.Either way, mortgage rates remain very low by historical standards even if they're now above the 3% mark, and industry experts anticipate that demand for mortgages will remain strong.The Mortgage Bankers Association \"continues to see a very strong housing market, with mortgage applications to buy a home increasing, even as refinance demand wanes,\" said Mike Fratantoni, the trade organization's chief economist. \"While mortgage rates are likely to move somewhat higher, the purchase market remains on track for a record year.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":454,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":324988739,"gmtCreate":1615952270521,"gmtModify":1704788859990,"author":{"id":"3573635568928452","authorId":"3573635568928452","name":"AntMan","avatar":"https://static.tigerbbs.com/d1008fe6c589933cfd307a9e79a22cd8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573635568928452","authorIdStr":"3573635568928452"},"themes":[],"htmlText":"WoW.... looking forward to that day.","listText":"WoW.... looking forward to that day.","text":"WoW.... looking forward to that day.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/324988739","repostId":"2120616977","repostType":4,"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362995113,"gmtCreate":1614584013832,"gmtModify":1704772680931,"author":{"id":"3573635568928452","authorId":"3573635568928452","name":"AntMan","avatar":"https://static.tigerbbs.com/d1008fe6c589933cfd307a9e79a22cd8","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573635568928452","authorIdStr":"3573635568928452"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/362995113","repostId":"1173400352","repostType":4,"repost":{"id":"1173400352","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1614583668,"share":"https://ttm.financial/m/news/1173400352?lang=&edition=fundamental","pubTime":"2021-03-01 15:27","market":"us","language":"en","title":"EU audits Indian vaccine maker as AstraZeneca looks to boost supplies to the bloc - source","url":"https://stock-news.laohu8.com/highlight/detail?id=1173400352","media":"Reuters","summary":"MILAN (Reuters) - Europe’s drug regulator is auditing the manufacturing site of the Serum Institute ","content":"<p>MILAN (Reuters) - Europe’s drug regulator is auditing the manufacturing site of the Serum Institute of India (SII), a source with knowledge of the matter said, a necessary step before AstraZeneca’s COVID-19 vaccine made there can be exported to the bloc.</p>\n<p>SII, the world’s largest vaccine manufacturer, is producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor and middle-income countries.</p>\n<p>The precise reason for the audit of SII’s manufacturing processes and facilities was not clear, but a green light would mean the drug could be exported to the European Union, the source said, declining to be identified because the review is confidential.</p>\n<p>The EU and Britain are mainly supplied by local facilities, but production problems have cut deliveries by the British-Swedish drugmaker to the EU, forcing it to look elsewhere.</p>\n<p>The European Medicines Agency (EMA) and European Commission, which has overseen the bloc’s supply contract with AstraZeneca, declined to comment specifically on the audit.</p>\n<p>But spokespeople for both organisations confirmed in emails the EMA would need to approve the site and change marketing authorisation for the shot to be exported to the bloc.</p>\n<p>A drugmaker would have to submit an application to the EMA to approve the change, the EMA spokesman said.</p>\n<p>SII and AstraZeneca both declined to comment on the matter.</p>\n<p>On Thursday, AstraZeneca chief executive Pascal Soriot told EU lawmakers he hoped to boost shipments to the 27-nation bloc in the second quarter, after the drop in the first three months of the year.</p>\n<p>Under its contract with the EU, the company has committed to delivering 180 million doses in the second quarter.</p>\n<p>He said the company will increase output in the second quarter using factories outside the EU that had no production problems, including in the United States.</p>\n<p>He did not mention SII. A senior EU official involved in talks with AstraZeneca told Reuters previously that SII could be a potential supplier.</p>\n<p>The Commission spokesman said the advance purchase agreement (APA) the EU has with AstraZeneca allows for manufacturing to happen elsewhere if authorised by EMA.</p>\n<p>“We therefore continue to discuss with the company possible ways to deliver the doses in line with the EU regulatory framework, with the APA and with our international commitments,” he said in the email.</p>\n<p>News of the audit comes after Reuters reported last month that the British drug watchdog has also been carrying out checks on the factory.</p>\n<p>The EMA has been evaluating the Serum plant for a week and could be finished by March, the source said.</p>\n<p>“You have to look at all the steps of production. The process right now is in a phase of virtual contacts and data requests,” he said. “No need for an in-person visit if the data are convincing.”</p>\n<p>As the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) carried out an audit with a physical visit, that might be enough for the EMA not to have to make its own checks on the ground, as it is a trusted agency.</p>\n<p>Brussels has set a target of vaccinating 70% of the EU’s adult population by the end of the summer, but has struggled to secure the doses promised by Pfizer and its partner BioNTech partners and AstraZeneca.</p>\n<p>Last week, SII said it was prioritising domestic vaccine needs and asked for patience from foreign governments awaiting their supply of COVID-19 shots.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU audits Indian vaccine maker as AstraZeneca looks to boost supplies to the bloc - source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU audits Indian vaccine maker as AstraZeneca looks to boost supplies to the bloc - source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-01 15:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MILAN (Reuters) - Europe’s drug regulator is auditing the manufacturing site of the Serum Institute of India (SII), a source with knowledge of the matter said, a necessary step before AstraZeneca’s COVID-19 vaccine made there can be exported to the bloc.</p>\n<p>SII, the world’s largest vaccine manufacturer, is producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor and middle-income countries.</p>\n<p>The precise reason for the audit of SII’s manufacturing processes and facilities was not clear, but a green light would mean the drug could be exported to the European Union, the source said, declining to be identified because the review is confidential.</p>\n<p>The EU and Britain are mainly supplied by local facilities, but production problems have cut deliveries by the British-Swedish drugmaker to the EU, forcing it to look elsewhere.</p>\n<p>The European Medicines Agency (EMA) and European Commission, which has overseen the bloc’s supply contract with AstraZeneca, declined to comment specifically on the audit.</p>\n<p>But spokespeople for both organisations confirmed in emails the EMA would need to approve the site and change marketing authorisation for the shot to be exported to the bloc.</p>\n<p>A drugmaker would have to submit an application to the EMA to approve the change, the EMA spokesman said.</p>\n<p>SII and AstraZeneca both declined to comment on the matter.</p>\n<p>On Thursday, AstraZeneca chief executive Pascal Soriot told EU lawmakers he hoped to boost shipments to the 27-nation bloc in the second quarter, after the drop in the first three months of the year.</p>\n<p>Under its contract with the EU, the company has committed to delivering 180 million doses in the second quarter.</p>\n<p>He said the company will increase output in the second quarter using factories outside the EU that had no production problems, including in the United States.</p>\n<p>He did not mention SII. A senior EU official involved in talks with AstraZeneca told Reuters previously that SII could be a potential supplier.</p>\n<p>The Commission spokesman said the advance purchase agreement (APA) the EU has with AstraZeneca allows for manufacturing to happen elsewhere if authorised by EMA.</p>\n<p>“We therefore continue to discuss with the company possible ways to deliver the doses in line with the EU regulatory framework, with the APA and with our international commitments,” he said in the email.</p>\n<p>News of the audit comes after Reuters reported last month that the British drug watchdog has also been carrying out checks on the factory.</p>\n<p>The EMA has been evaluating the Serum plant for a week and could be finished by March, the source said.</p>\n<p>“You have to look at all the steps of production. The process right now is in a phase of virtual contacts and data requests,” he said. “No need for an in-person visit if the data are convincing.”</p>\n<p>As the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) carried out an audit with a physical visit, that might be enough for the EMA not to have to make its own checks on the ground, as it is a trusted agency.</p>\n<p>Brussels has set a target of vaccinating 70% of the EU’s adult population by the end of the summer, but has struggled to secure the doses promised by Pfizer and its partner BioNTech partners and AstraZeneca.</p>\n<p>Last week, SII said it was prioritising domestic vaccine needs and asked for patience from foreign governments awaiting their supply of COVID-19 shots.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173400352","content_text":"MILAN (Reuters) - Europe’s drug regulator is auditing the manufacturing site of the Serum Institute of India (SII), a source with knowledge of the matter said, a necessary step before AstraZeneca’s COVID-19 vaccine made there can be exported to the bloc.\nSII, the world’s largest vaccine manufacturer, is producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor and middle-income countries.\nThe precise reason for the audit of SII’s manufacturing processes and facilities was not clear, but a green light would mean the drug could be exported to the European Union, the source said, declining to be identified because the review is confidential.\nThe EU and Britain are mainly supplied by local facilities, but production problems have cut deliveries by the British-Swedish drugmaker to the EU, forcing it to look elsewhere.\nThe European Medicines Agency (EMA) and European Commission, which has overseen the bloc’s supply contract with AstraZeneca, declined to comment specifically on the audit.\nBut spokespeople for both organisations confirmed in emails the EMA would need to approve the site and change marketing authorisation for the shot to be exported to the bloc.\nA drugmaker would have to submit an application to the EMA to approve the change, the EMA spokesman said.\nSII and AstraZeneca both declined to comment on the matter.\nOn Thursday, AstraZeneca chief executive Pascal Soriot told EU lawmakers he hoped to boost shipments to the 27-nation bloc in the second quarter, after the drop in the first three months of the year.\nUnder its contract with the EU, the company has committed to delivering 180 million doses in the second quarter.\nHe said the company will increase output in the second quarter using factories outside the EU that had no production problems, including in the United States.\nHe did not mention SII. A senior EU official involved in talks with AstraZeneca told Reuters previously that SII could be a potential supplier.\nThe Commission spokesman said the advance purchase agreement (APA) the EU has with AstraZeneca allows for manufacturing to happen elsewhere if authorised by EMA.\n“We therefore continue to discuss with the company possible ways to deliver the doses in line with the EU regulatory framework, with the APA and with our international commitments,” he said in the email.\nNews of the audit comes after Reuters reported last month that the British drug watchdog has also been carrying out checks on the factory.\nThe EMA has been evaluating the Serum plant for a week and could be finished by March, the source said.\n“You have to look at all the steps of production. The process right now is in a phase of virtual contacts and data requests,” he said. “No need for an in-person visit if the data are convincing.”\nAs the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) carried out an audit with a physical visit, that might be enough for the EMA not to have to make its own checks on the ground, as it is a trusted agency.\nBrussels has set a target of vaccinating 70% of the EU’s adult population by the end of the summer, but has struggled to secure the doses promised by Pfizer and its partner BioNTech partners and AstraZeneca.\nLast week, SII said it was prioritising domestic vaccine needs and asked for patience from foreign governments awaiting their supply of COVID-19 shots.","news_type":1},"isVote":1,"tweetType":1,"viewCount":157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":true}